Detection of MboII polymorphism at the 5′ promoter region of CYP3A4

被引：0
|
作者：
Cavalli, SA [1 ]
Hirata, MH [1 ]
Hirata, RDC [1 ]
机构：
[1] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508900 Sao Paulo, Brazil
来源：
CLINICAL CHEMISTRY | 2001年 / 47卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：348 / 351
页数：4
相关论文
共 50 条
  • [21] Association of a polymorphism of CYP3A4 with type 2 diabetes mellitus
    Yamada, Yoshiji
    Matsuo, Hitoshi
    Watanabe, Sachiro
    Kato, Kimihiko
    Yajima, Kazuhiro
    Hibino, Takeshi
    Yokoi, Kiyoshi
    Ichihara, Sahoko
    Metoki, Norifumi
    Yoshida, Hidemi
    Satoh, Kei
    Nozawa, Yoshinori
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2007, 20 (05) : 703 - 707
  • [22] CYP3A4 gene polymorphism is correlated with individual consumption of sufentanil
    Lv, J.
    Liu, F.
    Feng, N.
    Sun, X.
    Tang, J.
    Xie, L.
    Wang, Y.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2018, 62 (10) : 1367 - 1373
  • [23] CYP3A4 Genetic Polymorphism Influences Repaglinide's Pharmacokinetics
    Ruzilawati, A. B.
    Gan, S. H.
    PHARMACOLOGY, 2010, 85 (06) : 357 - 364
  • [24] Effects of Genetic Polymorphism in CYP3A4 and CYP3A5 Genes on Tacrolimus Dose Among Kidney Transplant Recipients
    Yousef, Al-Motassem
    Qosa, Hisham
    Bulatova, Nailya R.
    Abuhaliema, Ali
    Almadhoun, Hussein
    Khayyat, Ghada
    Olemat, Muhammad
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2016, 10 (03) : 156 - 163
  • [25] The distribution of genetic polymorphism of CYP3A5, CYP3A4 and ABCB1 in patients subjected to renal transplantation
    Vavic, Neven
    Rancic, Nemanja
    Cikota-Aleksic, Bojana
    Magic, Zvonko
    Cimesa, Jelena
    Obrencevic, Katarina
    Radojevic, Milorad
    Mikov, Momir
    Dragojevic-Simic, Viktorija
    VOJNOSANITETSKI PREGLED, 2016, 73 (07) : 663 - 667
  • [26] Screening of Genetic Polymorphisms of CYP3A4 and CYP3A5 Genes
    Leel, Jin Sol
    Cheong, Hyun Sub
    Kim, Lyoung Hyo
    Kixn, Ji On
    Seo, Doo Won
    Kim, Young Hoon
    Chung, Myeon Woo
    Han, Soon Young
    Shin, Hyoung Doo
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2013, 17 (06): : 479 - 484
  • [27] NEW TOOLS TO DIFFERENTIATE CYP3A4 AND CYP3A5 ACTIVITY
    Li, Xiaohai
    Kamenecka, Theodore M.
    Jeso, Valer
    Micalizio, Glen
    Heyward, Scott
    Walker, Gregory S.
    Cameron, Michael D.
    DRUG METABOLISM REVIEWS, 2015, 47 : 70 - 70
  • [28] The relative role of CYP3A4 and CYP3A5 in eplerenone metabolism
    McGraw, Joseph
    Cherney, Mitchell
    Bichler, Katherine
    Gerhardt, Armin
    Nauman, Mirielle
    TOXICOLOGY LETTERS, 2019, 315 : 9 - 13
  • [29] Domperidone as a substrate marker drug for CYP3A4 and CYP3A5.
    Michaud, V
    Simard, C
    Morin, N
    Turgeon, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P47 - P47
  • [30] Differential inhibition of CYP3A4 and CYP3A5 by verapamil.
    Wang, Y
    Jones, DR
    Hall, SD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P16 - P16
12345